A Randomized Phase 2 Trial of Axitinib and TRC105 versus Axitinib Alone (Including a Lead-in Phase 1B Dose-Escalation Portion) in Patients with Advanced or Metastatic Renal Cell Carcinoma

UCI-14-38
NCT01806064
Cancer - Kidney
John P Fruehauf
Open
Treatment
II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.